Chimerix and BARDA Announce Continued Partnership In The Development Of Brincidofovir For Smallpox, $17M Award
September 02, 2014 at 08:02 AM EDT
Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel, oral antivirals, today announced an award of $17.0 million ...
